A detailed history of Montchanin Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Montchanin Asset Management, LLC holds 11,422 shares of VRTX stock, worth $5.15 Million. This represents 4.9% of its overall portfolio holdings.

Number of Shares
11,422
Previous 10,737 6.38%
Holding current value
$5.15 Million
Previous $5.03 Million 5.54%
% of portfolio
4.9%
Previous 4.76%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$460.0 - $505.78 $315,100 - $346,459
685 Added 6.38%
11,422 $5.31 Million
Q2 2024

Jul 19, 2024

SELL
$392.81 - $485.53 $95,060 - $117,498
-242 Reduced 2.2%
10,737 $5.03 Million
Q1 2024

May 16, 2024

BUY
$407.69 - $446.08 $1.65 Million - $1.8 Million
4,044 Added 58.31%
10,979 $4.59 Million
Q2 2023

Aug 16, 2023

BUY
$314.42 - $351.91 $278,261 - $311,440
885 Added 14.63%
6,935 $2.44 Million
Q1 2023

May 10, 2023

BUY
$283.23 - $323.1 $559,379 - $638,122
1,975 Added 48.47%
6,050 $2.06 Million
Q4 2022

Feb 16, 2023

BUY
$285.76 - $321.48 $85,728 - $96,444
300 Added 7.95%
4,075 $1.18 Million
Q2 2022

Aug 16, 2022

BUY
$234.96 - $292.55 $886,974 - $1.1 Million
3,775 New
3,775 $1.06 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Montchanin Asset Management, LLC Portfolio

Follow Montchanin Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montchanin Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Montchanin Asset Management, LLC with notifications on news.